Comments on: NIH Funding Woes Are Hurting Innovation http://www.pharmalot.com/2008/03/nih-funding-woes-are-hurting-innovation/ News, Comment and Conversation Fri, 10 Feb 2012 18:18:02 +0000 http://wordpress.org/?v=2.6.2 By: Bob Freeman http://www.pharmalot.com/2008/03/nih-funding-woes-are-hurting-innovation/#comment-205597 Bob Freeman Wed, 12 Mar 2008 13:35:44 +0000 http://www.pharmalot.com/2008/03/nih-funding-woes-are-hurting-innovation/#comment-205597 One of the largely unnoticed factoids about NIH funding is that the average age of a recipient receiving his/her first RO1 grant has increased to 43 years of age. (I don't have the long-term stats.) This trend, in an isolated way, reflects the increasing difficulty of securing funding. Many research-intensive universities required the awarding of a RO1 NIH grant as a tenure/promotion criterion. This requirement is quietly being relaxed to reflect the realities of NIH funding. One of the largely unnoticed factoids about NIH funding is that the average age of a recipient receiving his/her first RO1 grant has increased to 43 years of age. (I don’t have the long-term stats.) This trend, in an isolated way, reflects the increasing difficulty of securing funding.

Many research-intensive universities required the awarding of a RO1 NIH grant as a tenure/promotion criterion. This requirement is quietly being relaxed to reflect the realities of NIH funding.

]]> By: Mo http://www.pharmalot.com/2008/03/nih-funding-woes-are-hurting-innovation/#comment-205554 Mo Wed, 12 Mar 2008 12:38:58 +0000 http://www.pharmalot.com/2008/03/nih-funding-woes-are-hurting-innovation/#comment-205554 Innovative research is no longer exclusively taking place at Ivy League institutions. Several public and private universities are very well able to compete with these institutions and I believe that professors who are used to getting easy grants are finding it difficult to compete with strong science and technology programs at public and private universities. Ivy League institutions have enormous endowments, why do they not invest these endowments if they believe in their worthy research efforts? Innovative research is no longer exclusively taking place at Ivy League institutions. Several public and private universities are very well able to compete with these institutions and I believe that professors who are used to getting easy grants are finding it difficult to compete with strong science and technology programs at public and private universities. Ivy League institutions have enormous endowments, why do they not invest these endowments if they believe in their worthy research efforts?

]]>